In biomedical applications, the high SA:V ratio of nanoparticles enhances their interaction with biological systems. Nanoparticles can be engineered to carry therapeutic agents and release them at targeted sites, improving the efficacy and reducing the side effects of treatments. For example, liposomes and dendrimers are used to deliver drugs directly to cancer cells, minimizing damage to healthy tissues.
